Anti-EGFR antibody conjugated gold liposome for molecular imaging and therapy on NSCLC cells
Project/Area Number |
22790770
|
Research Category |
Grant-in-Aid for Young Scientists (B)
|
Allocation Type | Single-year Grants |
Research Field |
Respiratory organ internal medicine
|
Research Institution | Tokyo Medical University |
Principal Investigator |
|
Project Period (FY) |
2010 – 2012
|
Project Status |
Completed (Fiscal Year 2012)
|
Budget Amount *help |
¥4,030,000 (Direct Cost: ¥3,100,000、Indirect Cost: ¥930,000)
Fiscal Year 2012: ¥1,300,000 (Direct Cost: ¥1,000,000、Indirect Cost: ¥300,000)
Fiscal Year 2011: ¥1,040,000 (Direct Cost: ¥800,000、Indirect Cost: ¥240,000)
Fiscal Year 2010: ¥1,690,000 (Direct Cost: ¥1,300,000、Indirect Cost: ¥390,000)
|
Keywords | 非小細胞肺癌 / ナノ粒子 / DDS(drug delivery system) / オートファジー / DDS / 金ナノ粒子 / Drug Delivery System / 抗EGFR抗体 / エンドサイトーシス / DDS (Drug Delivery System) |
Research Abstract |
In the present study, we investigated in vitro effect of these liposomes on EGFR-expressing/-null NSCLC cells. Our findings demonstrated that EGFR-targeted liposome is a promising agent for therapy and molecular imaging of NSCLC
|
Report
(4 results)
Research Products
(3 results)
-
-
[Presentation] EGFR-targeted gold liposome for molecular imaging and therapy on NSCLC cells.2012
Author(s)
Yokoyama T, Osato Y, Miyazawa K, Hayabe H, Miyasato A, Nomura M, Gotoh N, Itoi T, Tauchi T, Ikeda N, Ohyashiki K
Organizer
AACR 103th Annual meeting 2012
Place of Presentation
Chicago USA
Related Report
-